Skinvisible Pharmaceuticals (OTCQB: SKVI) is investing in long term growth with its network marketing subsidiary Kintari.
It is a natural that Skinvisible products play a major role in network marketing. After all when you look at some of the biggest names in networking marketing, you see companies that have skincare products. What makes Skinvisible in an excellent position to make a meaningful impact in this arena is that the Company has a very unique and patent protected polymer that makes the application of skincare products so much better. More on that this week – see below for details.
Kintari is the name of Skinvisible’s subsidiary that will do this. I am sure regular members on our site saw this release from SKVI earlier this month:
Skinvisible Announces Expansion With a New Scientific Skincare Company – “Premium Invisicare Powered Kintari(TM) Products Go to Market”
In that release, the SKVI announced this new subsidiary. The CEO of Skinvisible, Terry Howlett, commented in the release:
“Investment in our new subsidiary Kintari reflects Skinvisible’s ongoing commitment to maximize value for our shareholders,” said Mr. Terry Howlett, CEO of Skinvisible. “We have ambitious plans for many products. Our R&D pipeline consists of over thirty cosmeceutical and over-the-counter formulations which are available for Kintari to market. Our plan is to leverage the direct sales model to tell the Invisicare story which is the foundation of all our great products.” He added, “With the United States and Canadian markets planned for a fourth quarter launch, Kintari will start generating revenue in Q4.” In line with Skinvisible’s direct sales strategy,
The release of course stressed that Skinvisible Pharmaceuticals Inc. will continue to build its patent portfolio and its core business of R&D and licensing our prescription product line focused on dermatology conditions.
TOMORROW:
- We are going to look at some of the PUBLIC COMPANIES that are MAJOR PLAYERS in NETWORK MARKETING.
- We are going to show where SKINCARE COMPANIES have a unique advantage for success with NETWORK MARKETING… And Why that is true.
LATER THIS WEEK:
- The Company’s CEO is very experienced with Network Marketing. Additionally, the Company has made two recent new hires that also have key experience.
- The Polymer we spoke is also coming later this week. You can do some advance reading on that if you like at http://www.invisicare.com.
John Pentony now represents Skinvisible Pharmaceuticals, Inc. as its investor relations coordinator internally. In the past John Pentony’s company was hired for the distribution of news and blogs about Skinvisible. John Pentony and any family member or associated companies do not hold shares, warrants or other positions in Skinvisible stock. In years past John Pentony’s company (Pentony Enterprise LLC / “PE”) has received a total of eight thousand in cash payments. In 2009 PE was compensated 500k shares of restricted stock. John Pentony has signed a contract to as investor relations for Skinvisible, and will be paid up to eleven thousand dollars during the next twelve months should the contract go for twelve months as expected.